By Hong Xiuhai
The author focused on the generation of traditional business in 2018, following the "traditional pharmaceutical business into the only road of e-commerce - generation of operations", "to grasp the three stages of the development of B2B pharmaceutical e-commerce," after a long time without posting a long speech. However, after participating in the Hubei Electricity Salon, there are some feelings, emotionally in the circulation of pharmaceutical e-commerce boom, emotionally in the pharmaceutical industry, many friends of the dedication, but also to answer the confusion in the circulation of how to go on the issue of e-commerce. This article invited a long time, the Spring Festival before I had time to organize it, but also as I do pharmaceutical e-commerce agency operations this year's summary and the outlook for the 2019 pharmaceutical circulation of e-commerce.
At the beginning of 2018, with the fear of pharmaceutical e-commerce and the beginning of pharmaceutical distribution e-commerce, I set up a pharmaceutical e-commerce agency in the industry with my friends (Paiyou Technology).
Friends who have been exposed to B2C are not unfamiliar with the term "on behalf of the operation", but for those in the distribution industry, few people are clear. This is also my year with the traditional business leaders, often to brainwash a word. Of course, too much e-commerce technology, they do not need to familiarize themselves with, so that on the contrary, they will feel that e-commerce is too far away from them.
And when you say it differently - "contracted e-commerce department", they immediately realized. The next will ask to some revealing words: "You can do five million monthly sales in three months? I have the money, the product is not a problem."
Of course the people who can ask these questions have realized that if they don't act, they may not wait to be eliminated by the policy has been eliminated by the industry. Fortunately, in the three clients I serve, there is no longer any rejection of e-commerce.
My clients are in three categories.
The first category is municipal distribution companies that go for stable cash flow. Since it is going cash flow, and thus the sales volume of 200 million per year. Customer types are mainly clinics and small pharmacies. The product type is mainly large circulation and small general medicine.
The highlights of the enterprise are the strong business ability of the purchasing staff, the end customers are old customers, and the customer relationship in the region is relatively good. In fact, from the point of view of the existing business, the enterprise is not particularly eager to do e-commerce transactions. First, the customer base is well-maintained, and there is no rush to develop extra-territorial markets in the region. Second, the enterprise book cash flow is stable and healthy, e-commerce cash trading advantage is not prominent. Third, the procurement channels are diverse, relatively stable products. But surprisingly, the top management of the enterprise still decided to "touch the net", of course, in the case of not investing too much energy and money.
From the point of view of the operation, with very little risk of trial and error, is the advantage of e-commerce services. In short, on behalf of the operating company to invest in manpower, the enterprise to invest a small amount of money; on behalf of the operating company to import resources, the enterprise to import products. The biggest risk for companies entering the field of pharmaceutical e-commerce is that a large number of recruits are good at what they do.
On behalf of the operating company to invest in a team to assist commercial companies to carry out e-commerce business, sorting out the traditional internal business processes (financial processes, logistics and delivery processes, the first camp information filing process), to carry out on-line business management (up and down the shelf management, order returns, order normal audit, activity management). The purpose of the initial phase is to "test the money", measuring the overall profitability of the e-commerce, measuring the categories of goods suitable for online sales, measuring the overall service system can support e-commerce transactions, measuring the online business for what kind of platform site, measuring the existing business is suitable for e-commerce self-support.
Although not all pharmaceutical distribution companies are suitable for e-commerce, it is encouraging to see that after 1 year of cooperation with the agency, the company's e-commerce business has taken shape, and only through 1 e-commerce platform to open a store, there are already more than 100 new customers per month, 300,000-500,000 sales, and the net profit reaches 2%, which is more than the majority of pharmaceutical e-commerce distribution companies in Hubei and Guangdong.
The second type of business, annual sales of 400 million, the customer base is more mixed, covering the entire suburb. The owner is 80 years later, accepting new things faster, both vigor and ability, more actively embrace the Internet. Before he cooperated with me, he had already opened stores in several A platform websites, with monthly sales of not less than 1.5 million. His confusion is that the sales went up, but the cost increased.
We know that pharmaceutical commercial companies to carry out online sales, the expenses are roughly divided into: transportation costs (courier logistics fees, material costs), transaction commissions (platform deposit, A platform transaction commissions), platform activity fees, the three major parts. In addition, there are a number of random costs, such as the first qualification courier fees, courier warranty fees, return and exchange fees, breakage fees, taxes. I have calculated that as long as the online transaction is carried out, at least 4 points of fees are consumed without carrying out attraction activities. This will inevitably lead to some of the goods online is a loss-making sales. So the commercial company in the case of rough operation, due to operating costs of the assessment of the limitations of the inevitable online do not dare to do preferential activities.
In the case of the correct accounting cost categories, strategic diversion activities are necessary. If you do not have too many advantageous varieties, the advantages of generic drugs and is not large, such a situation does not do activities can also do a good job of online sales profits. For example, many platforms have online chat tools, such as pharmacist help. Such a platform can generally track customer browsing records, for such customers, do targeted combined with unfamiliar visits is also necessary. For example, a Heilongjiang customer, at the end of the year, visited the mall many times in the poly Ruipu zinc, the Department of Electricity can be the main push poly Ruipu zinc this kind of goods.
At the same time, the product inventory and price positioning. Online sales and offline *** with an ERP inventory. Online sales are less than the stage of offline transactions, you can only choose to prioritize shipments. So that once the form of lock stock is not taken, it is inevitable that the normal inventory of online orders can not be guaranteed. Even if the system is docked correctly, it will lead to a bad customer experience. So doing e-commerce is not a sales problem, but a decision-making problem. What is certain is that high gross products need to ensure that there is normal inventory.
Solve the inventory problem, is to optimize the product pricing. 4P theory, price, channel, promotion, product is indispensable. The good thing is that the meticulous generation of operation is based on evidence, not blind pricing and online Shunga 2% pricing. I think the pricing here is dependent on the product. That is, on what kind of products, in order to decide what price to book. Not blindly what inventory goods are on line, how to pick the specific goods have their own views, there is no need to repeat here. From the pricing point of view, you need to do some detailed work. Comparison of competing prices and the actual situation of the platform, rather than based on the traditional pricing strategy in the region.
For example, Bayxin Tong (nifedipine controlled-release tablets 30mg * 7) has a minimum price of $32.8, and the penultimate three prices are $33 / box, $33.1 / box, and there is plenty of stock. Our base price is $28/box, and without participating in promotions, the pricing space is above $28+X/box (excluding tax). Thus the base pricing comes out. On this basis also need to take into account whether the goods are in short supply, seasonal, commonly used, replaceable, etc..
The third category is, with regional resources and 90% share of the enterprise. The enterprise inventory of 12,000 kinds of goods, hospital distribution resources, state-controlled and other state-owned enterprises background, annual sales of 1 billion, net sales of 700 million. The enterprise set up their own up to 8 people in the Department of Electricity. Do half a year due to a variety of reasons, resulting in e-commerce transaction scale to enhance not up, has been maintained at 1.5 million / month or less. At the same time also due to e-commerce sales profits are not enough to support the department's costs, and therefore the e-commerce department staff downsized to 3 people. In fact, the problems they encountered in e-commerce were efficiency and low member purchasing stickiness.
Efficiency is a problem that Paiyou solves with tools. Being on multiple platforms caused confusion in order and inventory statistics processing. Some companies have to increase manpower to fill high-volume order billing issues. But this is like quenching thirst, increasing labor costs and reducing profits. Take the corresponding work, through the A platform orders and internal erp, from the new user first camp record, to order generation to order entry, order out of stock, a key to complete. Hubei Qiyuan, thousand Ruiming and other enterprises are also operating in this way.
At the same time, the commodity pricing process will encounter the problem of pricing options for commodities on sale. 12,000 kinds of commodities, saleable commodities by 8,000 kinds of, if in accordance with the method of manual comparison of prices of competing products on different A platforms for small business companies, it will surely cost a lot of manpower. Paiyou also encountered such a problem in the actual operation process, and is now developing a data analysis tool for different platforms, which matches the commodity code, grabs the competitor's price and determines whether to participate in promotions. This forms an analytical EXCEL, which allows operations and merchandising personnel to realize timely pricing.
To summarize. This year's generation of operation did encounter a lot of miscellaneous things, pharmaceutical distribution e-commerce is no longer a simple judgment to do or not to do. The new channels of the network is a necessary choice for any enterprise. In Guangdong Puning, Hubei Wuhan, Sichuan Chengdu, has appeared the first batch of "new medicine circulation enterprise". They seize the moment, relying on the Internet channel to change the simple transaction of buying and selling, adding capital flow and the concept of volume for price, the fastest capital turnover rate to obtain a large number of effective terminals, in order to industrial enterprises to "show muscle", so as to obtain more industrial support.
At the end of 2018, I participated in a pharmaceutical distribution e-commerce sharing salon held in Hubei. The original venue to accommodate 50 people, came 120 people, I was y impressed by the passion of the participants, in Hubei to do a good job in the pharmaceutical distribution of e-commerce is so much, want to and are doing e-commerce layout of the enterprise is even more.
A long time ago, I saw the individual pharmaceutical e-commerce platform to burn money to play, the real value of the platform down to sink to the terminal, the commercial service is not reflected, the industrial promotional policies continue to be intercepted. And now I come out of the confusion, and through 1 year of practical operation, concluded that the depth of the operation can make the real value of e-commerce empowered to the whole industry.
In 2018, the pharmaceutical circulation e-commerce is on the rise, many brand industries are paying more and more attention to online brand sales and price maintenance; different A platforms are seeking to increase the amount of money to increase the profitability; more and more commercial circulation enterprises to participate in the construction of e-commerce channels; terminals are also gradually developing the habit of online procurement and replenishment.
In the process of visiting Fujian commercial companies, a more obvious case. A good online sales of a drug, such as pediatric elimination of accumulation of food oral solution (Lunan 10ml * 10) offline in the Fujian region and not much sales, the product was not controlled sales, but when the online sales in May surged, the sales area is concentrated in the Jiangsu, Shandong region, by the local agent's complaint, the manufacturer began to control the sale of the product, which resulted in the online sales are not allowed. Similarly, there are also products such as zinc polyurethane, this treatment of gastric acid and gastritis strength of the product at the end of the Northeast region of the procurement volume and hoarding volume is large, resulting in regional shortages. Thus, the terminal through the platform to find the Fujian District has such a product, so the manufacturer has also implemented the control of sales restrictions. There are too many such varieties.
On the one hand, industrial enterprises are increasingly strict control of online sales of goods, on the other hand, a part of the industry to try to go online new product sales attempts. Andorra Wheeler antibacterial gel is a female private anti-bacterial products, from the product's customer base to lock and the product's industrial characteristics have a greater room for growth. The distributor hopes to use "brand building + online sales" as a way to develop the market in the early stage. In terms of brand building, the introduction of new media (public number + micro-video) to do online education and accurate crowd targeting. In terms of sales channel construction, it adopts B2C+B2B*** together with the online channel strategy for individual sales and distributors. This is an early case of traditional industrial enterprises trying to use Internet thinking to do branding. Of course, few people within the traditional industrial enterprises can carry out such cross-border work, in this process, the industrial brand acts as an integrated resource role. Of course the results of doing so are also very good.
In fact, as early as a few years ago, when B2C was in full swing, a part of the industrial brand (Ealing, Tonghua Jinma) also had a deep cooperation with Kang Aiduo, Jianke.com. Only the all-round three-dimensional integration of B2C, B2B, new media, and Internet hospitals together only began in 2018.
Let's envision this scenario: the target patient has a physical ailment, searches online for information about the disease, learns about the patient's friends and shares; at the same time, consults with a professional physician in the Internet hospital; next, the physician understands the condition, recommends a certain over-the-counter medicine or device, and instructs the patient how to use it, and how to go to the designated pharmacy clinic to get the goods; the patient purchases the goods through the B2C channel or the offline The patient purchases the goods through the B2C channel or offline 020 channel; at the same time, the pharmaceutical products in the B2B channel are pre-completed with stocking and channel construction. This completes a small closed loop of the new retail of medicines.
Layout of new retail led by industrial brands is a new change in 2019, and drug brand companies can no longer ignore the importance of e-commerce to them.
Circulation business in 2019 to consider more is the incremental volume and increase in profits. Thus, it needs to get rid of the previous rough online operation method and turn into refined operation. This has been mentioned many times in the previous part. A part of the commercial positioning of the new circulation business, part of the commercial adhere to the traditional with Internet sales, the other part of the resources have the strength of the commercial more in the layout of the whole industry chain.
No matter what kind of change, are not the previous sloppy thinking, just take the e-commerce as a tool and a new channel is no longer working, is more rational to combine their own characteristics of the integration of the Internet. Hubei's Zhongze business, from its own point of view, only do new special drugs and prescription drugs wholesale; Chengdu Bayou in the existing sales network based on the addition of 26,000 kinds of products, the development of terminal SAAS tool layout industry chain, Shandong medical state people lock high margin OEM products to do in-depth control of sales.
In 2019, pure A platform and pure B business has become more and more diluted. That is to say, the platform thinking has the change of regionalized self-owned malls, and the business of doing well has the thinking of doing virtual platforms.
Pharmacists help, 1 drug city and other platforms focus on fostering large transaction volume, terminal activity of the commercial company, take the form of acquisition, shareholding, and table, participate in the platform of the depth of the service construction, strengthen the terminal of the controllable, the goods of the controllable, and then realize the profit growth and sustained. And do a good job of commercial companies have tasted the sweetness of online transactions, see clearly the value of capital flow to traditional enterprises, turn to seek cross-regional business alliances, from the perspective of the tools to achieve unified management, product inventory **** enjoyment, commodity profits controllable.
From the point of view of the pharmaceutical A platform operator to see the pharmaceutical distribution e-commerce, is also suitable for "rational". In 2018 there are two relatively large financing in the industry, one is Gangling Group's U.S. IPO, and the other is the pharmacist's help of 420 million yuan C round and 133 million U.S. dollars D round of financing. As a three-party platform, the amount of the D round of financing reflects the attitude of the market and capitalists towards the A platform model. In my opinion, the financing is not much.
There is not yet a unicorn in the distribution e-commerce industry has a lot to do with the current profit model is not clear, and the impact of the profit model has to do with the platform scale and industrial base. In China's 1,100 billion drug market in 30% in out-of-hospital sales, 70% in the hospital.
That is, 300 billion in the circulation market, 33% market penetration rate in developed countries is the average level of pharmaceutical e-commerce. Thus, in the future, China's pharmaceutical circulation e-commerce market volume of about 100 billion. If the average profit margin of 1.5% for the standard calculation, the overall circulation market produces 1.5 billion in profit per year. Here said medicine A platform is currently still focused on the sale of large general medicine products.
The other trillion dollars in the field of big health belongs to the market of health care products, devices and daily necessities. I believe that in 2019 there will be a part of the platform to focus on such a class of differentiated products. Here we have to talk about Akorn Health, which was founded in 2005, has more than 13 years of prescription drug business foundation, the business scope from the initial hospital prescription drug market to extend to today's out-of-hospital and 2C market, the model from the drug B2B to expand to the core of the disease, the combination of DTP + CDC, the combination of 2B + 2C, the combination of online and offline integrated supply chain system, to extend the
Pure land grab does not represent access to the end of the sticky strong, commercial convergence is an inescapable law, on the one hand, look at the form of price comparison of the platform enterprise has the value of existence, differentiated categories of platforms also have a strong impact. Hopefully, in the not too distant one or two years, there will be a one hundred billion dollar pharmaceutical e-commerce unicorn.
In the first two years, the word "empowerment" often appeared in major Internet forums. In my opinion, only from the perspective of the industry chain can we give more value. In other words, empowerment, on the one hand, is the upgrading of the breadth. For example, in the transaction process of buying and selling, one party turns the main attributes of the product into necessary attributes, and the product into a service, thus turning the original behavior into multi-frequency, high-value and irreplaceable. On the other hand, empowerment is the deep value reconstruction. a platform in addition to building the trading environment, summarize the commercial company and the terminal of the purchase and sale, but also increased SAAS services, so that the purchase and sale of more convenient, smooth, savings; increase the supply chain financial products and services, so that the capital is more efficient.
In the process of empowerment, take the A certificate platform, has been paying more attention to the role of big data, which is the real value of the platform. Massive order data can be analyzed to determine the sales ranking of goods (sales ranking by generic name, brand name sales ranking, regional sales ranking, etc.). If these data are developed, they can be used by buyers to optimize the product structure and lower the price of goods by stocking up in advance, and at the same time, they can also be used to give commercial companies reasonable pricing and reasonable stocking up.
In fact, it is clear that the empowerment is based on the rational optimization of certain links or the entire chain to the industry chain. The depth of empowerment is to promote the benign development of the industry chain.
Unfortunately, some platforms are under pressure to survive and do not open up their data, and therefore do not have a professional data analysis team to analyze operational data. There are also several platforms that coincidentally do both as a player and a referee. Some commercial company sales staff feedback, stationed in a number of platform mall, commodity normal sales for a period of time, some hot high gross commodities will not sell. The reason is, on the one hand, the platform has a conscious control of the mall's traffic entrance; on the other hand, high gross commodities have no advantage. Because other commercial competitor companies and platforms have the sense to get more price advantageous products through other means.
Similarly, industry in the whole pharmaceutical e-commerce link more need to play the role of empowerment. In particular, some of the functional industry and CSO team to do specialty products, their past energy in the hospital, to maintain the doctor customer relations. With the change of relevant policies, as well as the new start of Internet sales channels, it is necessary to re-examine the market. There are some industrial practices, with the help of Internet hospitals to open a brand area, industry directly do professional patient education. If patients need medicines and health services, and then guided by physicians to offline channels, or O2O direct distribution. This is not only to the terminal to attract traffic and provide convenience to patients.
It can be seen that empowerment is no longer an empty word, empowerment is the linkage of the industry chain, empowerment is a deeper and more professional service.
Pharmaceutical circulation e-commerce after 2018, if you want to have a stronger sense of belonging to the terminal, commercial companies, brand industry, you need to embrace the 2030 strategy with a bigger heart, and actively respond to the market changes brought about by the 4+7 policy, prescription outflow, and consistency evaluation.
In the past 1 year, the author has seen all kinds of changes in the drug market, combined with the relevant medical and pharmaceutical policies, analyzed to the 2019 pharmaceutical circulation e-commerce may have the following trends.
1. Connect upstream and downstream with healthy business data.
Healthy data requires a foundation of massive end-user data, supplier data, commodity data, and transaction order data. The " healthy " here refers to data that is real, complete, and able to record the data of the entire industry transactions. Instead of the platform's fake data.
From the industry's attitude, platform-based enterprises need to establish responsibility and accountability. I have always advocated that the platform to open up part of the data, of course, commercial data also have privacy, such as a certain commercial transaction data, species structure, the number of species. By the way, from the point of view of the operation, commercial companies can accept, paid to buy the platform of the relevant data finished products. Through the data can provide member management for the new and old members of the effective setting of the policy; through the data analysis can be for the commodity how to new, how to reasonable pricing to do the judgment; can also be given to the operating staff to do planning or carry out platform activities, give direct support.
In my opinion, any real data is valuable. And many commercial distribution companies do e-commerce, there is no lack of data, the lack of tools and ideas to analyze data.
The value of data is multi-dimensional comparison out, but the premise is that the comparison in a unified environment. As an example, the sales data of the pharmaceutical A platform can only represent the online nationwide sales, not a small range. Online and offline purchasing habits and users are inconsistent leading to differences in sales data. Under the impact of Internet sales, it is quite meaningless for a commercial company to use the region's sales ranking to locate how much online channel sales can sell.
Similarly, the platform range of goods sales ranking, need to refer to different platforms sales differences, need to refer to different regional sales differences, need to refer to seasonal medication, need to refer to the bidding price of different drugs and so on. All of these, which requires operators to continue to analyze the data uninterruptedly, to make purchasing predictions.
The current pharmaceutical platform strategy focuses on the layout, which results in a lack of analytical tools like B2C platforms (Taobao, Tmall, Jingdong). In immature platforms, a great deal of work can only be done by commodity data analysts.
In addition, SAAS software can assist the terminal scientific management of inventory, reduce procurement risk, improve procurement efficiency, and forced by the confidentiality of the terminal data restrictions, its role is far from being tapped. From an industrial perspective, there is even less lack of tools and channels to collect commodity data. As policies change and marketing ideas are chosen, manufacturers will have access to more realistic data with which to guide commodity pricing and sales tasks.
2. Empowering terminals with big health product sales solutions.
At first glance, many people may think that it is to do product and program output. Indeed, such an approach is the practice of CSO companies and agencies. However, now quietly emerging several other platforms, one is the OEM mall, the second is the DTP mall, three is a non-pharmaceutical mall, and the fourth is a specialty mall. These categories from a certain sense to get rid of the pure price comparison platform model, in order to ensure that the interests of the terminal on the basis of service-driven procurement, the mall is just a tool for the output of the product. The bigger difference is that professional services as the core to drive online sales.
If the device mall, the mall side output a complete set of replicable customer diversion, unit price enhancement, customer education set of home medical equipment sales service solutions, used to solve the terminal sales of the worries of the problem, the terminal must be firmly locked. A terminal on the platform, purchased a full set of home equipment, to a certain amount of time, the platform will be stationed in the local small team, to assist in the education of the staff, merchandise zone display. At the same time, in the sale stage, the relevant service personnel will guide individual users to use and associated sales of other products; in the later stage of the equipment recovery and maintenance, the platform will also assist in solving. This service to drive the mall sales, to achieve a multi **** win.
In addition, when a category is locked, other affiliated varieties will eventually be purchased on the mall. In other words, as the platform's main point of profitability in the future, may be a service platform for multiple specialized product solutions. And such a big health product sales program chains and terminals are equally needed.
In 2018, "Internet hospital" is undoubtedly one of the hot words in the medical circle. From a policy perspective, "Internet + medical health" has finally settled, and a number of policies have been introduced around the world to foster and encourage. The platform type website has the ability and need to build their own Internet hospital platform, and the role of Internet hospitals in the whole industry chain is undoubtedly very important.
First of all, it is conducive to the diversion of drugs between the terminal and individuals. Individuals through the Internet hospital consulting problems, and by the doctor to guide to the pharmacy to buy drugs. Thus completing a simple medical consultation and medication services. Although this part does not seem to be related to B2B transactions, it can actually be seen as a value-added service provided by the platform for the terminal. Secondly, for chronic disease-related illnesses, through the diversion of Internet hospitals, it can increase the sales of categories related to chronic diseases at the terminal. Increase the sales of pharmacies. Once again, the Internet hospital actually builds a "physician + pharmacist" service system for small chains and single pharmacies. Finally, customer education and staff education for new products can be accomplished through Internet hospitals. As long as the industrial brand gives enough support to the Internet hospital, its new products can be exported to the pharmacy through the B2B mall, and then sold to individuals through the pharmacy.
There are two factors in making this judgment.
1. platform-based website survival: do business, control goods, increase commissions.
In 2018, although there are rumors that many platforms have financed again, and some companies are going to be platforms, the market is still in the Spring and Autumn period. First, no platform has more than half of the number of terminals. The terminals here include pharmacies, clinics, and health centers. Second, no platform has an overall sales market share of more than 60%. Third, within the industry, there is not yet a mature business model mature. Overall, the oligarchy of pharmaceutical e-commerce platforms has not yet emerged.
Looking quietly at the A platform company in 2018, the pharmacist help, No. 1 City relies on the advantages of scale, acquiring and participating in a number of commercial companies. By doing so, they hope to realize the flow of water with their products. In fact, as early as 2016, the drug terminal network in Chengdu also tried to run its own business. The purpose of doing so is obvious to everyone without saying. Relying on big data mining high-value goods to achieve realization, and then realize positive capital flow, self-blood creation, get rid of the embarrassment of pure capital investment, so that you can focus on fostering the core business, but also feed a large number of ground pushers.
But the risk of doing so also exists. The platform to sell goods will lose the attribute of fairness of the platform type of enterprise, both as a player and as a referee. Many commercial companies have already voiced complaints, because commercial companies in the platform of hot commodities, turn to the platform will be scooped up.
Another place where commercial companies complain is the increase in commissions. Part of the platform to the commercial company's charges are: in addition to the deposit, the annual fee, and the province's trading water 1% commission, 3% commission of the regional trading water in foreign provinces. Although it is said that the platform charges are justified, because the platform pays for the system, builds a trading platform, the ground push team to assist in the promotion and so on. However, commercial companies are now trading on the platform is basically not earning money. The previous article has already talked about this problem of profit. So, commercial companies are also actively responding to such changes.
2. Traditional commercial companies upgraded to new pharmaceutical e-commerce commercial companies.
Commercial companies doing general medicine distribution and delivery into the field of e-commerce, their profits are difficult to control. Of course the new pharmaceutical commercial company in the e-commerce sales environment, see the highlights of the traditional business operations with different.
Simply put, this is no longer the difference between a sitting business and a traveling business. The new pharmaceutical business company is through e-commerce channels and means to quickly realize the accumulation of effective users, the rapid flow of funds. The purpose is to obtain long-term business value enhancement and enterprise valuation enhancement.
From the point of view of sales channels, new pharmaceutical commercial companies will try to cooperate with multiple A platform, and eventually form 1-3 stable platform partnerships. Although it is said that they do not value the net profit of each single of the e-commerce, there will be losses and wins, but in order to control the risk, many new pharmaceutical commercial companies began to establish a stable, can control their own sales channels of the mall. This is from the drug online trading policy, there has been no obstacle, just from the point of view of the health operation, the new pharmaceutical business company is still slightly inexperienced.
From the point of view of the overall market changes, as well as chatting with some of the new pharmaceutical commercial company bosses, they are very interested in the commercial company with a "B license" to do "A license" attempt. Take the words of one of the bosses, "my brothers are in other provinces to open companies, using my mall to sell their inventory."
Do not know for the moment such an operation, how strong is the maneuverability? The first time I saw this is when I was in the middle of the night, and I was in the middle of the night. This "B license" to do "A license" idea is in line with the Internet thinking.
It is worthwhile to determine that in 2019, the pharmaceutical e-commerce circulation market is still "Spring and Autumn and Warring States". Maybe in the field of pharmaceutical e-commerce, there are still a lot of places we can not see through, however, "Spring and Autumn and Warring States" period from the point of view of the idea, is the outbreak of a number of ideas. The traditional business will be more and more difficult to do, and the pipe in the leopard will make the pharmaceutical e-commerce to a dead end. If you use an article to make it clear how to go with the circulation of pharmaceutical e-commerce, certainly not comprehensive, and even a little bit of the flavor of the class. From the perspective of mutual learning and sharing, in 2019, I personally hope to build a communication platform for partners who are interested in the cause of pharmaceutical distribution e-commerce to communicate and learn.
So, don't care so much, do it.